Protective Effects of Elaeagnus angustifolia Leaf Extract against Myocardial IschemiaReperfusion Injury in Isolated Rat Heart

Abstract EN

The purpose of this study is to clarify the cardioprotective property of the aqueous extract of Elaeagnus angustifolia L.

leaf (EA) against myocardial ischemia/reperfusion injury in isolated rat heart.

The myocardial ischemia/reperfusion (I/R) injury model of isolated rat heart was set up by the use of improved Langendorff retrograde perfusion technology.

Compared with the ischemia/reperfusion (I/R) group, the aqueous extract of Elaeagnus angustifolia L.

leaf (0.5 mg/mL, 1.0 mg/mL) pretreatment markedly improved the coronary flow (CF) and raised left ventricular developed pressure (LVDP) and maximum rise/down velocity (±dp/dtmax).

The infarct size of the EA-treated hearts was smaller than that of I/R group.

After treatment with EA, the superoxide dismutase (SOD) activity increased; malondialdehyde (MDA) and protein carbonyl content reduced more obviously (P<0.01) than that of I/R injury myocardial tissue.

Conclusion.

Results from the present study showed that the aqueous extract of Elaeagnus angustifolia L.

leaf has obvious protective effects on myocardial I/R injury, which may be related to the improvement of myocardial oxidative stress states.